Cassava Sciences, Alzheimer
A federal grand jury has indicted an embattled Alzheimer's researcher for allegedly falsifying data to fraudulently ...
Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.
The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, ...
The Chicago Tribune reports that a new system to help fair distribution of donor lungs was built on a flawed algorithm which harmed some sick and dying patients. Meanwhile a researcher was indicted on ...
With a second pricey drug to treat Alzheimer’s disease set to receive an approval decision soon, the nonprofit Alzheimer’s ...
Breakthrough is going to help treatment and drug trials, scientists say Charles Marshall thinks he can now predict who will get dementia up to nine years before their symptoms appear, with a ...
Scientists in Japan reversed the signs of Alzheimer’s in lab mice by restoring the healthy function of neuron synapses in ...
Journal Editorial Report: The week's best and worst from Bill McGurn, Allysia Finley, Mene Ukueberuwa and Dan Henninger. Image: Cristobal Herrera-Ulashkevich ...
A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers Monday, setting the stage for the treatment's expected approval for people with mild dementia caused ...
Hoau-Yan Wang, a 67-year-old tenured medical professor, was indicted this week for an alleged scheme involving fraudulent ...